Etracker Debug:
	et_pagename = "Journal of Pediatric Endocrinology and Metabolism|jpem|C|[EN]"
Jump to ContentJump to Main Navigation

Journal of Pediatric Endocrinology and Metabolism

Editor-in-Chief: Kiess, Wieland

Editorial Board Member: Darendeliler, Feyza / Gustafsson, Jan / Luo, Feihong / Mericq, Veronica / Lanes M. D., Roberto / Battelino, Tadej / Buyukgebiz, Atilla / Cassorla, Fernando / Chrousos, George P. / Cutfield, Wayne / Fideleff, Hugo L. / Hershkovitz, Eli / LaFranchi, Stephen H. / Mohn, Angelika / Root, Allen W. / Rosenfeld, Ron G. / Wabitsch, Martin / Werther, George / Zadik, Zvi

12 Issues per year

IMPACT FACTOR 2013: 0.711



Obesity and Reversed Growth Retardation in a Child with Type Ia Glycogen Storage Disease

Wikrom Karnsakul12 / Stacey Gillespie2 / Kathryn Skitarelic3 / Marybeth Hummel2

1Division of Pediatric Gastroenterology and Nutrition, Johns Hopkins University School of Medicine, Baltimore, Maryland, West Virginia, USA

2Robert C. Byrd Health Sciences Center, West Virginia University School of Medicine, Department of Pediatrics, West Virginia, USA

3Pathology, Morgantown, West Virginia, USA

Corresponding author: Wikrom Karnsakul,

Citation Information: Journal of Pediatric Endocrinology and Metabolism. Volume 23, Issue 5, Pages 507–512, ISSN (Online) 2191-0251, ISSN (Print) 0334-018X, DOI: 10.1515/jpem.2010.083, September 2010

Publication History

Published Online:


Type Ia Glycogen storage disease is an autosomal recessive hepatic metabolic disease due to a lack of glucose-6-phosphatase (G-6-Pase) activity presenting with growth retardation, lactic acidosis, fasting hypoglycemia with hypoinsulinemia, hyperuricemia, hepatomegaly, and hepatic adenoma with a risk of malignancy. The gene that encodes G-6-Pase was mapped to 17q21. There are some genotype-phenotype correlations. We report a case with delF327 mutation which is devoid of G-6-Pase activity; however clinical presentation in this case differs somewhat. Although correction of hypoglycemia and lactic acidosis with nocturnal intragastric feeding and uncooked starch therapy improves growth failure, mean height of the patients is often less than the target. Normal height and obesity in this case with hepatic steatosis and low hepatic glycogen storage requires clinical re-evaluation since there are some overlapping phenotypes between type Ia GSD and metabolic syndrome. The phenomenon may be related to insulin resistance as a consequence of early aggressive nutrition therapy with frequent low glycemic index meals.

KEY WORDS: glycogen storage disease type 1; obesity; insulin resistance; reversed growth retardation; hepatic steatosis

Comments (0)

Please log in or register to comment.
Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.